Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of Oral HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

NCT07712705 is registered in ClinicalTrials.gov with Newsoara Biopharma Co., Ltd. as lead sponsor.

NCT NCT07712705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07712705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of Oral HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.
Lead sponsor
Newsoara Biopharma Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
April 20, 2023
Completion date
February 20, 2025
Enrollment
515 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis